Bicycle Therapeutics PLC (BCYC)
20.58
+0.32
(+1.58%)
USD |
NASDAQ |
Nov 22, 14:28
Bicycle Therapeutics Total Assets (Quarterly): 996.75M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 996.75M |
| June 30, 2024 | 1.057B |
| March 31, 2024 | 547.14M |
| December 31, 2023 | 595.34M |
| September 30, 2023 | 638.68M |
| June 30, 2023 | 454.17M |
| March 31, 2023 | 428.80M |
| December 31, 2022 | 410.61M |
| September 30, 2022 | 417.15M |
| June 30, 2022 | 445.48M |
| March 31, 2022 | 459.56M |
| December 31, 2021 | 479.79M |
| Date | Value |
|---|---|
| September 30, 2021 | 281.33M |
| June 30, 2021 | 226.05M |
| March 31, 2021 | 223.84M |
| December 31, 2020 | 161.15M |
| September 30, 2020 | 170.06M |
| June 30, 2020 | 118.60M |
| March 31, 2020 | 129.28M |
| December 31, 2019 | 110.19M |
| September 30, 2019 | 116.06M |
| June 30, 2019 | 126.25M |
| March 31, 2019 | 77.80M |
| December 31, 2018 | 81.63M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
110.19M
Minimum
Dec 2019
1.057B
Maximum
Jun 2024
417.57M
Average
422.97M
Median
Total Assets (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 317.44M |
| NuCana PLC | 25.38M |
| TC BioPharm (Holdings) PLC | 9.171M |
| Autolus Therapeutics PLC | 827.49M |
| Biodexa Pharmaceuticals PLC | 17.67M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 165.71M |
| Shareholders Equity (Quarterly) | 831.03M |
| Current Ratio | 17.13 |
| Net Debt Paydown Yield | 0.39% |